Walvax Biotechnology: Announcement on the completion of share repurchase cancellation and changes in shareholding
Walvax Biotechnology: 2023 Annual Equity Distribution Implementation Notice
Walvax Biotechnology: Announcement on the completion of cancellation of some repurchased shares and changes in shares
Watson Biotech: Announcement on the implementation results of the repurchase of the company's shares and changes in shares
Watson Biotech: Announcement on 2023 Profit Distribution Plan
Watson Biotech: Progress announcement on the repurchase of company shares
Watson Biotech: Progress announcement on the repurchase of company shares
Watson Biotech: Progress announcement on the repurchase of company shares
Watson Biotech: Announcement on relinquishing priority purchase rights to transfer shares of holding subsidiaries and signing related agreements
Watson Biotech: Progress announcement on the repurchase of company shares
Watson Biotech: Progress announcement on the repurchase of company shares
Watson Biotech: Progress announcement on the repurchase of company shares
Watson Biotech: Progress announcement on the repurchase of company shares
Watson Biotech: Announcement on the completion of the cancellation of stock options under the 2018 Stock Options Incentive Plan
Watson Biotech: Announcement on cancellation of stock options already granted in part of the 2018 Stock Option Incentive Plan
Watson Biotech: Beijing Guofeng Law Firm\'s Legal Opinion on the Cancellation of Stock Options in the Company\'s 2018 Stock Options Incentive Plan
Watson Biotech: Progress announcement on the repurchase of company shares
Watson Biotech: Progress announcement on the repurchase of company shares
Watson Biotech: Announcement on the completion of the implementation plan of the company\'s chairman and the companies he controls to increase the company\'s shares
Watson Biotech: Announcement on relinquishing priority purchase rights to transfer shares of holding subsidiaries and signing related agreements
No Data